- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 88,460 | 21.06.24 09:48:52 | +0,330 | +0,37% | 88,430 | 88,490 | 87,920 | 88,130 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 968,800 | 21.06.24 08:10:06 | +0,400 | +0,04% | 970,600 | 976,800 | 968,800 | 968,400 |
